Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Another Isis oligonucleotide enters clinical testing

Sep. 10, 1997

Bexxar now administered on outpatient basis

Sep. 10, 1997

GSH prevents cisplatin-induced toxicity

Sep. 9, 1997

Treatment for preleukemic disorder from Milkhaus enters phase III

Sep. 9, 1997

GeneMedicine begins phase I testing of IL-2 Cancer Gene Medicine

Sep. 8, 1997

Novel integrin receptor antagonists from DuPont Merck

Sep. 8, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

DepoTech seeks Canadian approval for DepoCyt

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 24, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...